Merck & Co. Inc. (MRK) Stock: Revenue, Earnings, Margins & Valuation
Merck & Co. Inc. (MRK), USA at a glance: revenue structure, segments, costs, margins and earnings from the latest published annual report (FY 2025), visualised as a Sankey diagram and complemented by price chart, P/E valuation and the original SEC filings. All figures in USD. Free and without signup.
Merck & Co. Inc. key figures (FY 2025)
| Revenue | 65.01 USD bn |
|---|---|
| Gross profit | 55.68 USD bn |
| Gross margin | 85.7 % |
| Operating income | 22.63 USD bn |
| Operating margin | 34.8 % |
| Net income | 16.85 USD bn |
| Net margin | 25.9 % |
Merck & Co. Inc. revenue by segment (FY 2025)
| Segment | Revenue | Share |
|---|---|---|
| Pharmaceutical | 58.14 USD bn | 90.1 % |
| Animal Health | 6.35 USD bn | 9.9 % |
Merck & Co. Inc. earnings analysis
In the latest reported fiscal year (FY 2025), Merck & Co. Inc. generated revenue of 65.01 USD bn. The largest segment is Pharmaceutical with 58.14 USD bn, about 90.1 % of total segment revenue. From gross margin (85.7 %) through operating margin (34.8 %) to net margin (25.9 %), the Sankey diagram shows how much of each revenue dollar remains at each stage of the income statement.
Merck & Co. Inc. business model
The income statement of Merck & Co. Inc. is visualised as a Sankey diagram: from revenue through cost of revenue and operating expenses to net income. The page also shows the price chart, the price-earnings ratio of the last five fiscal years, return on equity and the company's annual and quarterly filings.
More stock analyses like Merck & Co. Inc.
- Abbott Laboratories stock (ABT)
- AbbVie Inc. stock (ABBV)
- Advanced Micro Devices stock (AMD)
- Alphabet (Google) stock (GOOGL)
- Amazon.com Inc. stock (AMZN)
- American Express stock (AXP)
- Amgen Inc. stock (AMGN)
- Amphenol Corp. stock (APH)
- Apple Inc. stock (AAPL)
- Applied Materials Inc. stock (AMAT)